Boenning Scattergood cut shares of Xylem Inc. (NYSE:XYL) from an outperform rating to a neutral rating in a research note released on Monday morning.

Several other brokerages have also issued reports on XYL. Royal Bank Of Canada lifted their price target on shares of Xylem from $47.00 to $51.00 and gave the company an outperform rating in a research note on Tuesday, August 16th. RBC Capital Markets set a $51.00 price target on shares of Xylem and gave the company a buy rating in a research note on Tuesday, August 16th. Canaccord Genuity reiterated a hold rating and issued a $50.00 price target (up from $45.00) on shares of Xylem in a research note on Tuesday, August 16th. Atlantic Securities upgraded shares of Xylem from a neutral rating to an overweight rating and set a $54.00 price target on the stock in a research note on Monday, August 22nd. Finally, Janney Montgomery Scott upgraded shares of Xylem from a neutral rating to a buy rating and lifted their price target for the company from $50.00 to $52.00 in a research note on Wednesday, November 2nd. Eight equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Xylem currently has an average rating of Buy and a consensus target price of $47.15.

Shares of Xylem (NYSE:XYL) opened at 51.64 on Monday. The firm’s 50-day moving average is $50.32 and its 200-day moving average is $48.42. Xylem has a 12-month low of $31.67 and a 12-month high of $54.99. The company has a market capitalization of $9.26 billion, a PE ratio of 28.66 and a beta of 1.18.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, November 1st. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.53 by $0.01. Xylem had a net margin of 8.83% and a return on equity of 16.38%. The company had revenue of $897 million for the quarter, compared to analysts’ expectations of $913.53 million. During the same period last year, the firm posted $0.49 earnings per share. The business’s quarterly revenue was down .6% compared to the same quarter last year. On average, equities research analysts anticipate that Xylem will post $2.04 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by Financial Market News and is owned by of Financial Market News. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright law. The correct version of this news story can be viewed at http://www.financial-market-news.com/xylem-inc-xyl-downgraded-to-neutral-at-boenning-scattergood/1208094/.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 7th. Shareholders of record on Wednesday, November 9th will be issued a $0.1549 dividend. This represents a $0.62 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Monday, November 7th. Xylem’s dividend payout ratio is currently 34.44%.

In other Xylem news, SVP Claudia S. Toussaint sold 5,300 shares of the business’s stock in a transaction dated Friday, November 4th. The shares were sold at an average price of $47.27, for a total value of $250,531.00. Following the completion of the sale, the senior vice president now owns 44,033 shares of the company’s stock, valued at approximately $2,081,439.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Colin R. Sabol sold 27,473 shares of the business’s stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $50.91, for a total transaction of $1,398,650.43. Following the completion of the sale, the insider now directly owns 65,530 shares of the company’s stock, valued at approximately $3,336,132.30. The disclosure for this sale can be found here. 0.77% of the stock is currently owned by company insiders.

A number of hedge funds have recently bought and sold shares of the stock. ETRADE Capital Management LLC acquired a new stake in Xylem during the third quarter worth about $358,000. Scout Investments Inc. acquired a new stake in Xylem during the third quarter worth about $27,492,000. Price T Rowe Associates Inc. MD increased its stake in Xylem by 0.4% in the third quarter. Price T Rowe Associates Inc. MD now owns 9,831,231 shares of the company’s stock worth $515,648,000 after buying an additional 40,520 shares in the last quarter. Quantitative Systematic Strategies LLC acquired a new stake in Xylem during the third quarter worth about $548,000. Finally, Somerville Kurt F increased its stake in Xylem by 1.6% in the third quarter. Somerville Kurt F now owns 77,688 shares of the company’s stock worth $4,074,000 after buying an additional 1,200 shares in the last quarter. 86.38% of the stock is owned by hedge funds and other institutional investors.

Xylem Company Profile

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.